[18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation?
Francesco DondiDomenico AlbanoFrancesco BertagnaRaffaele GiubbiniPublished in: Nuclear medicine review. Central & Eastern Europe (2022)
[18F]FDG PET/CT has good accuracy in evaluating patients with relapse or persistance of ovarian cancer. CA-125 levels were significantly correlated with metabolic PET/CT parameters.